DB05499ExperimentalSmall molecule
TAK-428 is a drug for treating diabetic neuropathy. It is based on the novel concept that peripheral nervous tissue that was damaged by diabetes can be repaired and regenerated by...
- Mechanism
- Curator reviewed
TAK-428 stimulates an increase in neurotrophic factors.
- Primary indication
- Investigated for use/treatment in neuropathy (diabetic).Curator reviewed
- Code names
- TAK-428
Which companies are running trials of TAK-428, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account